EGLN1 and fibrosarcoma: Moreover, studies have reported that targeting the autophagy-mediated ARNTL-EGLN1-HIF1A pathway may enhance the anti-cancer activity of ferroptosis activators in human non-small cell lung cancer cell lines, namely Calu-1 and HT1080 (a human fibrosarcoma cell line) [51].